Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - constitutive androstane receptor (CAR) - Bcr-Abl - Adenosine Kinases
清除全部
-
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂 -
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂 -
B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl抑制剂 -
A8812 PD173955Target: Bcr-Abl|SrcSummary: Src/Abl激酶双重抑制剂 -
A8604 GNF 5Target: Bcr-AblSummary: Bcr-Abl抑制剂 -
A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂 -
A5467 Ponatinib (AP24534)1 Citation中文名: 帕纳替尼Target: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL抑制剂，多激酶抑制剂 -
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂 -
A1805 Imatinib Mesylate (STI571)中文名: 甲磺酸伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR抑制剂 -
A2149 Bosutinib (SKI-606)1 Citation中文名: 伯舒替尼Target: Bcr-Abl|SrcSummary: Abl/Src有效的抑制剂